Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
A site for direct integrin αvβ6·uPAR interaction from structural modelling and docking.
Gopichandran Sowmya1, Javed Mohammed Khan1, Samyuktha Anand2
1Department of Chemistry and Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia; ARC Centre of Excellence in Bioinformatics, Macquarie University, Sydney, NSW, Australia.
Structural analysis reveals how integrin αvβ6 (a key protein in cancer) binds to urokinase plasminogen activating receptor (uPAR), identifying a specific interaction site for potential cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Integrin αvβ6 is an epithelial cell surface glycoprotein implicated in cancer progression.
- It interacts with urokinase plasminogen activating receptor (uPAR), a known factor in cancer.
- Complete structural data for αvβ6·uPAR interactions is currently lacking.
Purpose of the Study:
- To structurally analyze the interaction between integrin αvβ6 and uPAR.
- To identify the specific binding interface between these two molecules.
- To explore the therapeutic potential of targeting this interaction in cancer.
Main Methods:
- Utilized computational modeling and docking simulations to analyze αvβ6·uPAR interactions.
- Integrated previous experimental findings, including immunoprecipitation, mass spectrometry, proximity ligation assays, and peptide arrays.
- Correlated computational models with existing experimental data to validate findings.
Main Results:
- Pinpointed the molecular interface between integrin αvβ6 and uPAR through structural analysis.
- Confirmed that the β-propeller region of the integrin α-chain interacts with uPAR.
- Identified a specific peptide region in domain III of uPAR as consistent with the proposed 3D interaction site.
Conclusions:
- The study provides crucial structural insights into the αvβ6·uPAR binding mechanism.
- The identified interaction site offers a potential target for novel cancer therapeutics.
- Understanding this molecular interaction is vital for developing targeted cancer management strategies.
More Related Videos
Related Concept Videos
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Anchoring Junctions
Protein-protein Interfaces
Protein-Protein Interfaces

